Pregnant women are still largely excluded from clinical trials—leaving critical data gaps. ICON’s Liz O’Brien emphasises the need for trust, transparency, and education to safely include this population in research. Rea...
- Home
- News & Events
- Events
- Webinars
Webinars
-
Webinars
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Date 16 December 2025 Time 09:30 - 10:30 Location Webinar Timezone EST - America/New York -
Webinars
Riding the data wave: How pharma can navigate disruptions in open claims
Date 8 December 2025 Time 12:00 - 13:00 Location Webinar Timezone EST - America/New York -
Webinars
Becoming a sponsor of choice for high-performing sites
Date 3 December 2025 Time 10:00 - 11:00 Location Webinar Timezone ET - America/New York -
Webinars
Strategic approaches for early clinical trials in neurodegenerative diseases
Date 18 November 2025 Time 15:00 - 16:00 Location Webinar Timezone CET - Europe/Dublin -
Webinars
Beyond the bench: The advantages of GMP over USP compounding in early phase development
Date 6 November 2025 Time 11:00 - 12:00 Location Webinar Timezone ET - America/New York -
Webinars
Introducing ICON Strategic Solutions FSP Services: How This Model Supports Sponsors in Korea
Date 28 October 2025 Time 14:00 - 15:00 Location Webinar Timezone KST - Asia/Seoul -
Webinars
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
Date 22 October 2025 Time 11:00 - 12:00 Location Webinar Timezone EDT - America/New York -
Webinars
Identifying and mitigating risks in pediatric protocol development: Strategies, tools & access planning
Date 15 October 2025 Time 10:00 - 11:00 Location Webinar Timezone EDT - America/New York -
Webinars
Enhancing clinical trials in obesity by integrating clinical outcome assessment and digital health technologies
Date 7 October 2025 Time 11:00 - 12:00 Location Webinar Timezone ET - America/New York
ICON’s Webinar Channel
A library of recorded webinars exploring topics ranging from early to late phase.